Jack W Schuler - Net Worth and Insider Trading

Jack W Schuler Net Worth

The estimated net worth of Jack W Schuler is at least $224 Million dollars as of 2025-04-26. Jack W Schuler is the Director, 10% Owner of QuidelOrtho Corp and owns about 3,414,053 shares of QuidelOrtho Corp (QDEL) stock worth over $96 Million. Jack W Schuler is the Director of Medtronic PLC and owns about 644,658 shares of Medtronic PLC (MDT) stock worth over $54 Million. Jack W Schuler is also the Director of Stericycle Inc and owns about 682,602 shares of Stericycle Inc (SRCL) stock worth over $42 Million. Besides these, Jack W Schuler also holds Biodesix Inc (BDSX) , Accelerate Diagnostics Inc (AXDX) , Transition Therapeutics Inc (TTHI) , Soleno Therapeutics Inc (SLNO) , Neos Therapeutics Inc (NEOS) , Aspira Womens Health Inc (AWHL) , Oncternal Therapeutics Inc (ONCT) , Yield10 Bioscience Inc (YTENQ) , Biolase Inc (BIOLQ) . Details can be seen in Jack W Schuler's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jack W Schuler has not made any transactions after 2024-12-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Jack W Schuler

Jack W Schuler Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jack W Schuler owns 12 companies in total, including Yield10 Bioscience Inc (YTENQ) , Aspira Womens Health Inc (AWHL) , and Soleno Therapeutics Inc (SLNO) among others .

Click here to see the complete history of Jack W Schuler’s form 4 insider trades.

Insider Ownership Summary of Jack W Schuler

Ticker	Company	Transaction Date	Type of Owner
YTENQ	Yield10 Bioscience Inc	2023-12-20	10 percent owner
AWHL	Aspira Womens Health Inc	2023-07-24	10 percent owner
SLNO	Soleno Therapeutics Inc	2022-12-09	10 percent owner
		2024-12-03	director & 10 percent owner
		2018-01-22	director
		2020-02-11	10 percent owner
		2018-03-01	director & Chairman
		2017-02-17	10 percent owner
		2015-06-15	director & 10 percent owner
		2014-03-21	director & 10 percent owner
		2011-11-22	10 percent owner
		2024-11-21	director & 10 percent owner

Jack W Schuler Latest Holdings Summary

Jack W Schuler currently owns a total of 12 stocks. Among these stocks, Jack W Schuler owns 3,414,053 shares of QuidelOrtho Corp (QDEL) as of January 22, 2018, with a value of $96 Million and a weighting of 42.84%. Jack W Schuler owns 644,658 shares of Medtronic PLC (MDT) as of May 10, 2013, with a value of $54 Million and a weighting of 24.23%. Jack W Schuler also owns 682,602 shares of Stericycle Inc (SRCL) as of March 1, 2018, with a value of $42 Million and a weighting of 18.9%. The other 9 stocks Biodesix Inc (BDSX) , Accelerate Diagnostics Inc (AXDX) , Transition Therapeutics Inc (TTHI) , Soleno Therapeutics Inc (SLNO) , Neos Therapeutics Inc (NEOS) , Aspira Womens Health Inc (AWHL) , Oncternal Therapeutics Inc (ONCT) , Yield10 Bioscience Inc (YTENQ) , Biolase Inc (BIOLQ) have a combined weighting of 14.03% among all his current holdings.

Latest Holdings of Jack W Schuler

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
QDEL	QuidelOrtho Corp	2018-01-22	3,414,053	28.09	95,900,749
MDT	Medtronic PLC	2013-05-10	644,658	84.16	54,254,417
SRCL	Stericycle Inc	2018-03-01	682,602	61.98	42,307,672
BDSX	Biodesix Inc	2024-11-21	31,194,935	0.54	16,814,070
AXDX	Accelerate Diagnostics Inc	2024-12-03	8,336,110	0.58	4,814,604
TTHI	Transition Therapeutics Inc	2011-11-22	2,823,010	1.52	4,304,526
SLNO	Soleno Therapeutics Inc	2022-12-09	36,595	73.26	2,680,950
NEOS	Neos Therapeutics Inc	2015-07-28	2,324,481	1.15	2,673,153
AWHL	Aspira Womens Health Inc	2023-07-24	1,883,656	0.06	118,670
ONCT	Oncternal Therapeutics Inc	2014-03-21	4,404	0.53	2,319
YTENQ	Yield10 Bioscience Inc	2023-12-20	2,658	0.02	40
BIOLQ	Biolase Inc	2020-02-11	304	0.01	3

Holding Weightings of Jack W Schuler

Jack W Schuler Form 4 Trading Tracker

According to the SEC Form 4 filings, Jack W Schuler has made a total of 0 transactions in QuidelOrtho Corp (QDEL) over the past 5 years. The most-recent trade in QuidelOrtho Corp is the sale of 12,000 shares on January 22, 2018, which brought Jack W Schuler around $582,000.

According to the SEC Form 4 filings, Jack W Schuler has made a total of 0 transactions in Medtronic PLC (MDT) over the past 5 years. The most-recent trade in Medtronic PLC is the sale of 34,230 shares on May 10, 2013, which brought Jack W Schuler around $2 Million.

According to the SEC Form 4 filings, Jack W Schuler has made a total of 0 transactions in Stericycle Inc (SRCL) over the past 5 years. The most-recent trade in Stericycle Inc is the acquisition of 10,000 shares on March 1, 2018, which cost Jack W Schuler around $625,900.

More details on Jack W Schuler's insider transactions can be found in the Insider Trading History of Jack W Schuler table.

Insider Trading History of Jack W Schuler

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jack W Schuler Trading Performance

GuruFocus tracks the stock performance after each of Jack W Schuler's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jack W Schuler is 14%. GuruFocus also compares Jack W Schuler's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jack W Schuler within 3 months outperforms 114 times out of 208 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jack W Schuler's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jack W Schuler

Average Return

Average return per transaction

Outperforming Transactions

90 out of 206 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	10.18
Relative Return to S&P 500(%)	8.36

Jack W Schuler Ownership Network

Ownership Network List of Jack W Schuler

No Data

Ownership Network Relation of Jack W Schuler

Jack W Schuler Owned Company Details

What does Yield10 Bioscience Inc do?

Who are the key executives at Yield10 Bioscience Inc?

Jack W Schuler is the 10 percent owner of Yield10 Bioscience Inc. Other key executives at Yield10 Bioscience Inc include VP Planning and Comms Lynne H Brum , VP Fin and CAO Charles B Haaser , and VP Research & CSO Kristi Snell .

Yield10 Bioscience Inc (YTENQ) Insider Trades Summary

Over the past 18 months, Jack W Schuler made 3 insider transaction in Yield10 Bioscience Inc (YTENQ) with a net sale of 107,000.

In summary, during the past 3 months, insiders sold 0 shares of Yield10 Bioscience Inc (YTENQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,458 shares of Yield10 Bioscience Inc (YTENQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,458 shares.

Yield10 Bioscience Inc (YTENQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Yield10 Bioscience Inc Insider Transactions

No Available Data

What does Aspira Womens Health Inc do?

Who are the key executives at Aspira Womens Health Inc?

Jack W Schuler is the 10 percent owner of Aspira Womens Health Inc. Other key executives at Aspira Womens Health Inc include General Counsel & Secretary Minh Hoang Merchant , Chief Financial Officer Torsten Hombeck , and CSO & COO Ryan Thinh Phan .

Aspira Womens Health Inc (AWHL) Insider Trades Summary

Over the past 18 months, Jack W Schuler made no insider transaction in Aspira Womens Health Inc (AWHL). Other recent insider transactions involving Aspira Womens Health Inc (AWHL) include a net purchase of 14,493 shares made by Nicole Sandford , and a net sale of 980 shares made by Minh Hoang Merchant .

In summary, during the past 3 months, insiders sold 0 shares of Aspira Womens Health Inc (AWHL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 980 shares of Aspira Womens Health Inc (AWHL) were sold and 14,493 shares were bought by its insiders, resulting in a net purchase of 13,513 shares.

Aspira Womens Health Inc (AWHL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aspira Womens Health Inc Insider Transactions

No Available Data

What does Soleno Therapeutics Inc do?

Who are the key executives at Soleno Therapeutics Inc?

Jack W Schuler is the 10 percent owner of Soleno Therapeutics Inc. Other key executives at Soleno Therapeutics Inc include See Remarks Patricia C Hirano , 10 percent owner Vivo Opportunity Fund Holdings, L.p. , and See Remarks Kristen Yen .

Soleno Therapeutics Inc (SLNO) Insider Trades Summary

Over the past 18 months, Jack W Schuler made no insider transaction in Soleno Therapeutics Inc (SLNO). Other recent insider transactions involving Soleno Therapeutics Inc (SLNO) include a net sale of 210,617 shares made by Patricia C Hirano , a net sale of 1,199,559 shares made by Bhatnagar Anish , and a net sale of 179,374 shares made by Kristen Yen .

In summary, during the past 3 months, insiders sold 2,944,640 shares of Soleno Therapeutics Inc (SLNO) in total and bought 0 shares, with a net sale of 2,944,640 shares. During the past 18 months, 5,807,319 shares of Soleno Therapeutics Inc (SLNO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 5,807,319 shares.

Soleno Therapeutics Inc (SLNO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Soleno Therapeutics Inc Insider Transactions

No Available Data

What does Accelerate Diagnostics Inc do?

Who are the key executives at Accelerate Diagnostics Inc?

Jack W Schuler is the director & 10 percent owner of Accelerate Diagnostics Inc. Other key executives at Accelerate Diagnostics Inc include director & PRESIDENT AND CEO Jack Phillips , Chief Technology Officer Larry Michael Mertz , and Chief Financial Officer David Patience .

Accelerate Diagnostics Inc (AXDX) Insider Trades Summary

Over the past 18 months, Jack W Schuler made 1 insider transaction in Accelerate Diagnostics Inc (AXDX) with a net sale of 200,000. Other recent insider transactions involving Accelerate Diagnostics Inc (AXDX) include a net sale of 95,749 shares made by Jack Phillips , a net sale of 21,094 shares made by David Patience , and a net sale of 16,846 shares made by Larry Michael Mertz .

In summary, during the past 3 months, insiders sold 34,217 shares of Accelerate Diagnostics Inc (AXDX) in total and bought 0 shares, with a net sale of 34,217 shares. During the past 18 months, 333,689 shares of Accelerate Diagnostics Inc (AXDX) were sold and 200,000 shares were bought by its insiders, resulting in a net sale of 133,689 shares.

Accelerate Diagnostics Inc (AXDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Accelerate Diagnostics Inc Insider Transactions

No Available Data

What does QuidelOrtho Corp do?

Who are the key executives at QuidelOrtho Corp?

Jack W Schuler is the director of QuidelOrtho Corp. Other key executives at QuidelOrtho Corp include 10 percent owner Carlyle Group Inc. , Chief Financial Officer Joseph M Busky , and SVP & Chief Information Officer Louise Brandy .

QuidelOrtho Corp (QDEL) Insider Trades Summary

Over the past 18 months, Jack W Schuler made no insider transaction in QuidelOrtho Corp (QDEL). Other recent insider transactions involving QuidelOrtho Corp (QDEL) include a net sale of 12,460,183 shares made by Carlyle Group Inc. , a net purchase of 6,033 shares made by Brian J Blaser , and a net purchase of 2,150 shares made by Joseph M Busky .

In summary, during the past 3 months, insiders sold 0 shares of QuidelOrtho Corp (QDEL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 12,460,183 shares of QuidelOrtho Corp (QDEL) were sold and 8,183 shares were bought by its insiders, resulting in a net sale of 12,452,000 shares.

QuidelOrtho Corp (QDEL)'s detailed insider trading history can be found in Insider Trading Tracker table.

QuidelOrtho Corp Insider Transactions

No Available Data

What does Biolase Inc do?

Who are the key executives at Biolase Inc?

Jack W Schuler is the 10 percent owner of Biolase Inc. Other key executives at Biolase Inc include 10 percent owner Goldman Sachs Group Inc , 10 percent owner Goldman Sachs & Co. Llc , and Chief Financial Officer Jennifer Bright .

Biolase Inc (BIOLQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Biolase Inc (BIOLQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Biolase Inc (BIOLQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Biolase Inc (BIOLQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Biolase Inc Insider Transactions

No Available Data

What does Stericycle Inc do?

Who are the key executives at Stericycle Inc?

Jack W Schuler is the director & Chairman of Stericycle Inc. Other key executives at Stericycle Inc include EVP & Chief People Officer Joseph Anthony Reuter , EVP C&RS White Stephen Cory , and Chief Financial Officer Daniel Ginnetti .

Stericycle Inc (SRCL) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Stericycle Inc (SRCL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Stericycle Inc (SRCL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Stericycle Inc (SRCL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Stericycle Inc Insider Transactions

No Available Data

What does Neos Therapeutics Inc do?

Who are the key executives at Neos Therapeutics Inc?

Jack W Schuler is the 10 percent owner of Neos Therapeutics Inc. Other key executives at Neos Therapeutics Inc include director & Chief Executive Officer Gerald W. Mclaughlin , Chief Financial Officer Richard I Eisenstadt , and SVP & General Counsel John M Limongelli .

Neos Therapeutics Inc (NEOS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Neos Therapeutics Inc (NEOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Neos Therapeutics Inc (NEOS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Neos Therapeutics Inc (NEOS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Neos Therapeutics Inc Insider Transactions

No Available Data

What does Hansen Medical Inc do?

Who are the key executives at Hansen Medical Inc?

Jack W Schuler is the director & 10 percent owner of Hansen Medical Inc. Other key executives at Hansen Medical Inc include 10 percent owner Oracle Partners Lp , 10 percent owner Larry N Feinberg , and 10 percent owner Oracle Associates Llc .

Hansen Medical Inc (HNSN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Hansen Medical Inc (HNSN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Hansen Medical Inc (HNSN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Hansen Medical Inc (HNSN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Hansen Medical Inc Insider Transactions

No Available Data

What does Oncternal Therapeutics Inc do?

Who are the key executives at Oncternal Therapeutics Inc?

Jack W Schuler is the director & 10 percent owner of Oncternal Therapeutics Inc. Other key executives at Oncternal Therapeutics Inc include director & Executive Chairman Robert James Wills , Chief Scientific Officer Gunnar F. Kaufmann , and Chief Medical Officer Salim Yazji .

Oncternal Therapeutics Inc (ONCT) Insider Trades Summary

Over the past 18 months, Jack W Schuler made no insider transaction in Oncternal Therapeutics Inc (ONCT). Other recent insider transactions involving Oncternal Therapeutics Inc (ONCT) include a net purchase of 9,020 shares made by Robert James Wills , and a net purchase of 980 shares made by David F Hale .

In summary, during the past 3 months, insiders sold 0 shares of Oncternal Therapeutics Inc (ONCT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 980 shares of Oncternal Therapeutics Inc (ONCT) were sold and 10,980 shares were bought by its insiders, resulting in a net purchase of 10,000 shares.

Oncternal Therapeutics Inc (ONCT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Oncternal Therapeutics Inc Insider Transactions

No Available Data

What does Transition Therapeutics Inc do?

Who are the key executives at Transition Therapeutics Inc?

Jack W Schuler is the 10 percent owner of Transition Therapeutics Inc. Other key executives at Transition Therapeutics Inc include and 10 percent owner Family Foundation Schuler .

Transition Therapeutics Inc (TTHI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Transition Therapeutics Inc (TTHI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Transition Therapeutics Inc (TTHI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Transition Therapeutics Inc (TTHI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Transition Therapeutics Inc Insider Transactions

No Available Data

What does Biodesix Inc do?

Who are the key executives at Biodesix Inc?

Jack W Schuler is the director & 10 percent owner of Biodesix Inc. Other key executives at Biodesix Inc include director & President & CEO Scott Hutton , Chief Commercial Officer Kieran O'kane , and Chief Development Officer Gary Anthony Pestano .

Biodesix Inc (BDSX) Insider Trades Summary

Over the past 18 months, Jack W Schuler made 3 insider transaction in Biodesix Inc (BDSX) with a net purchase of 400,253. Other recent insider transactions involving Biodesix Inc (BDSX) include a net sale of 163,063 shares made by Scott Hutton , a net sale of 47,427 shares made by Robin Harper Cowie , and a net sale of 31,122 shares made by Kieran O'kane .

In summary, during the past 3 months, insiders sold 146,229 shares of Biodesix Inc (BDSX) in total and bought 0 shares, with a net sale of 146,229 shares. During the past 18 months, 277,471 shares of Biodesix Inc (BDSX) were sold and 643,953 shares were bought by its insiders, resulting in a net purchase of 366,482 shares.

Biodesix Inc (BDSX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Biodesix Inc Insider Transactions

No Available Data

Jack W Schuler Mailing Address

Above is the net worth, insider trading, and ownership report for Jack W Schuler. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Jack W Schuler's mailing address is: Lake Forest Il 60045.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.